Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine

被引:67
作者
Beretta, S
Sala, G
Mattavelli, L
Ceresa, C
Casciati, A
Ferri, A
Carrì, MT
Ferrarese, C
机构
[1] Univ Milano Bicocca, San Gerardo Hosp, Dept Neurosci & Biomed Technol, I-20052 Monza, MI, Italy
[2] Ctr Neurobiol Sperimentale Mondino Tor Vergata S, Rome, Italy
[3] CNR, Inst Neurosci, Sect Psycobiol & Psycopharmacol, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy
关键词
amyotrophic lateral sclerosis; SOD1; oxidative stress; mitochondrial function; n-acetylcysteine;
D O I
10.1016/S0969-9961(03)00043-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We report that the expression of mutant G93A copper/zinc superoxide dismutase (SOD1), associated with familial amyotrophic lateral sclerosis, specifically causes a decrease in MTT reduction rate and ATP levels and an increase in both cytosolic and mitochondrial reactive oxygen species (ROS) production in human neuroblastoma SH-SY5Y cells compared to cells overexpressing wild-type SOD1 and untransfected cells. Exposure to N-acetylcysteine lowers ROS production and returns mitochondrial functional assays to control levels. No large aggregates of human SOD1 are detectable under basal growth conditions in any of the investigated cell lines. After proteasome activity inhibition, SOD I aggregates can be detected exclusively in G93A-SOD1 cells, even though they do not per se enhance cell death compared to control cell lines. Our findings indicate that mitochondrial homeostasis is affected by mutant SOD1-generated ROS independently from the formation of aggregates and that this alteration is reversed by antioxidants. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 48 条
  • [1] N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis
    Andreassen, OA
    Dedeoglu, A
    Klivenyi, P
    Beal, MF
    Bush, AI
    [J]. NEUROREPORT, 2000, 11 (11) : 2491 - 2493
  • [2] Palliative care in amyotrophic lateral sclerosis
    Borasio, GD
    Voltz, R
    Miller, RG
    [J]. NEUROLOGIC CLINICS, 2001, 19 (04) : 829 - +
  • [3] Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO
  • [4] 2-8
  • [5] SUPEROXIDE-DISMUTASE ACTIVITY, OXIDATIVE DAMAGE, AND MITOCHONDRIAL ENERGY-METABOLISM IN FAMILIAL AND SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    BOWLING, AC
    SCHULZ, JB
    BROWN, RH
    BEAL, MF
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (06) : 2322 - 2325
  • [6] SOD1 aggregates in ALS: Cause, correlate or consequence?
    Brown, RH
    [J]. NATURE MEDICINE, 1998, 4 (12) : 1362 - 1364
  • [7] Browne SE, 1998, J NEUROCHEM, V71, P281
  • [8] Is ALS caused by an altered oxidative activity of mutant superoxide dismutase?
    Bush, AI
    [J]. NATURE NEUROSCIENCE, 2002, 5 (10) : 919 - 919
  • [9] Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells
    Carri, MT
    Ferri, A
    Battistoni, A
    Famhy, L
    Gabbianelli, R
    Poccia, F
    Rotilio, G
    [J]. FEBS LETTERS, 1997, 414 (02) : 365 - 368
  • [10] Oxidative modulation of nuclear factor-κB in human cells expressing mutant fALS-typical superoxide dismutases
    Casciati, A
    Ferri, A
    Cozzolino, M
    Celsi, F
    Nencini, M
    Rotilio, G
    Carrì, MT
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 83 (05) : 1019 - 1029